Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling
about
Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potentialNeutralizing tumor-promoting chronic inflammation: a magic bullet?Clinical significance of tumor-infiltrating lymphocytes in breast cancerBreakthroughs in genomics data integration for predicting clinical outcomeIdentifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression dataReprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection.Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.The immune microenvironment of breast ductal carcinoma in situ.Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function.Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance.T-box transcription factor 21 expression in breast cancer and its relationship with prognosis.Stromal expression of miR-21 identifies high-risk group in triple-negative breast cancer.Improving breast cancer survival analysis through competition-based multidimensional modeling.Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.Systematic genomic identification of colorectal cancer genes delineating advanced from early clinical stage and metastasisA microRNA signature associated with early recurrence in breast cancer.Critical analysis of the potential for microRNA biomarkers in breast cancer management.Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution.Designing vaccines to prevent breast cancer recurrence or invasive disease.Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patientsLymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53.Differential immune cell densities in ductal carcinoma In-Situ and invasive breast cancer: Possible role of leukocytes in early stages of carcinogenesis.Progress in breast cancer research.Subtype and pathway specific responses to anticancer compounds in breast cancer.DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer.HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ.Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: interdisciplinary approaches.An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity.DNA methylation signatures for breast cancer classification and prognosisInterleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells.Can pharmacological receptor tyrosine kinase inhibitors sensitize poor outcome breast tumors to immune-based therapies?A Molecular Portrait of High-Grade Ductal Carcinoma In Situ.Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade.Tumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro.Clinicopathological significance of STAT4 in hepatocellular carcinoma and its effect on cell growth and apoptosis.Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detection.The immune system and inflammation in breast cancer.MerTK inhibition in tumor leukocytes decreases tumor growth and metastasisSTAT signaling in different breast cancer sub-types.
P2860
Q26782613-3AD9AA8D-C0F7-447E-A719-78732148DF37Q26830931-ECD9BAF3-7711-4BE8-85E9-BD6E991A5511Q28070214-E2DA6FB7-4224-4BD4-B8AB-8319509C53E4Q28708853-D15E1D93-9665-4577-970F-F063A281A443Q30587051-7EF872B5-D794-441C-9365-287A604BB95DQ33581986-C9626AB7-2D27-4913-A8B5-61E539FEEC42Q33670486-D7A399C3-7637-4E69-8DD7-4C1A29274052Q33674704-767233C7-B384-4AF8-9CBB-6013CAF4A4E4Q33834968-40428B42-7406-4157-B993-06A929EF4715Q34285190-4741106F-114F-447F-A1DC-E7833F35CF92Q34346725-2BFF6C17-79BF-4D4E-9057-C6E619361004Q34502054-4E9511FA-AE01-4AAB-ADDB-86B09A704D8FQ34647811-5A0826AB-7BE5-4665-B95C-4AC149B58744Q34720254-9514AE34-4D2E-4539-BB75-3717AA95A6AAQ35000651-8BE907E8-430F-46CF-8EFD-4A55925AE4ADQ35059602-403B8F34-B9A8-4E79-B03E-60E34009BFC1Q35121814-6399C231-E4C9-4596-A038-341C3C796C66Q35137273-5EF1C400-5C22-40EE-8D96-F8C8B767EA66Q35140121-113855AE-18EA-4754-A62E-65DDCCBF80E1Q35546337-D553552D-123F-400F-9A58-6C7AC20C4BDCQ35595696-617B3D3B-F779-4D6E-9F25-38D64EF6102BQ35737352-64060AFD-C76C-48B4-8976-0C9E73406304Q35765833-B19369FB-638B-4199-A99A-3BBFE0F7C6C8Q35779144-FE2982D4-7390-4BB3-9241-020A9FAF8B7FQ35779241-69DC1047-9D8F-4BEB-B323-F3E37570F0F2Q35888926-0194A736-767B-4597-8161-46A1E0043C1BQ35899068-E0F947DF-9048-4BE5-941B-2E5660C18274Q36023456-B73B02BB-35B3-404E-B086-D7EA0A6BDF39Q36187733-C638BB05-CC5C-4B77-AF4F-4E06BAA27C08Q36245189-DCA67C5D-670A-4CF4-8C89-52A20A0065BCQ36597474-A3BC24F3-B286-4540-BD26-BFCF22404096Q36605526-97E05278-BC3C-44DE-8493-90B04DACDF2CQ36622366-50570B1D-C4F0-4DEA-9344-C61AB80C1E77Q36653524-D4F33A65-C383-49A0-8344-62B154535977Q36695084-C01178E9-7F7A-4D9C-B8FB-A440671A9092Q36729248-441DFCA3-8E6E-4A0E-B700-C13F5808AEE6Q36991435-3670FBB7-E2CF-4509-AB67-3B5F47CA8717Q37033451-7210EABE-B15F-42F5-9DE3-D4CFF40FA170Q37052927-C3CA8C8B-A518-4873-8857-E1170E01139CQ37086768-02FBBD02-CBAF-44D1-9DD5-8CAEC2F1C495
P2860
Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Integrated molecular profiles ...... ular and interleukin signaling
@ast
Integrated molecular profiles ...... ular and interleukin signaling
@en
type
label
Integrated molecular profiles ...... ular and interleukin signaling
@ast
Integrated molecular profiles ...... ular and interleukin signaling
@en
prefLabel
Integrated molecular profiles ...... ular and interleukin signaling
@ast
Integrated molecular profiles ...... ular and interleukin signaling
@en
P2860
P50
P356
P1476
Integrated molecular profiles ...... ular and interleukin signaling
@en
P2093
Josie Ursini-Siegel
Ravi Sachidanandam
P2860
P304
P356
10.1073/PNAS.1108781108
P407
P50
P577
2011-09-09T00:00:00Z